1. Soyama H, Nishio M, Otani J, Sakuma T, Takao S, Hara S, Masuda T, Mimori K, Toyokuni S, Lydon J, Nakao K, Mishina H, Fukumoto T, Maehama T, Suzuki A*. Hippo-TAZ signaling is the master regulator of the onset of triple negative basal-like breast cancers. Proc Tatl Acad Sci. USA. in press.
2. Wang D, Sun L, Okuda S, Yamamoto D, Nakayama M, Oshima H, Saito H, Kouyama Y, Mimori K, Ando T, Watanabe S, and Oshima M*. Nano-scale physical properties characteristic to metastatic intestinal cancer cells identified by high-speed scanning ion conductance microscope. Biomaterials, 2022, 280, 121256, doi: 10.1016/j.biomaterials.2021.121256.
3. Masuda T, Mimori K*. Artificial intelligence-assisted drug repurposing via chemical-induced gene expression ranking" Patterns (N Y) 2022 Apr 8;3(4):100470. doi: 10.1016/j.patter.2022.100470. 査読有"
4. Takahashi J, Masuda T, Kitagawa A, Tobo T, Nakano Y, Abe T, Ando Y, Kosai K,Kobayashi Y, Matsumoto Y, Yoshizumi T, Mori M, Mimori K*. Fanconi Anemia Complementation Group E, a DNA Repair-Related Gene, Is a Potential Marker of Poor Prognosis in Hepatocellular Carcinoma. Oncology. 2022, 100(2):101-113. doi:10.1159/000520582.
5. Koike K, Masuda T, Sato K, Fujii A, Wakiyama H, Tobo T, Takahashi J, Motomura Y, Nakano T, Saito H, Matsumoto Y, Otsu H, Takeishi K, Yonemura Y, Mimori K*,Nakagawa T. GET4 is a novel driver gene in colorectal cancer that regulates the localization of BAG6, a nucleocytoplasmic shuttling protein. Cancer Sci. 2022, 113(1):156-169. doi: 10.1111/cas.15174.
6. Shimizu D, Taniue K, Matsui Y, Haeno H, Araki H, Miura F, Fukunaga M, Shiraishi K, Miyamoto Y, Tsukamoto S, Komine A, Kobayashi Y, Kitagawa A, Yoshikawa Y, Sato K, Saito T, Ito S, Masuda T, Niida A, Suzuki M, Baba H, Ito T, Akimitsu N, Kodera Y, Mimori K*. Pan-cancer methylome analysis for cancer diagnosis and classification of cancer cell of origin. Cancer Gene Ther. 2021, doi: 10.1038/s41417-021-00401-w.
7. Sakano Y, Noda T, Kobayashi S*, Kitagawa A, Iwagami Y, Yamada D, Tomimaru Y, Akita H, Gotoh K, Asaoka T, Tanemura M, Umeshita K, Mimori K, Doki Y, Eguchi H. Clinical Significance of Acylphosphatase 1 Expression in Combined HCC-iCCA, HCC, and iCCA. Dig Dis Sci. 2021, doi: 10.1007/s10620-021-07266-x.
8. Hirata H, Niida A, Kakiuchi N, Uchi R, Sugimachi K, Masuda T, Saito T, Kageyama SI, Motomura Y, Ito S, Yoshitake T, Tsurumaru D, Nishimuta Y, Yokoyama A, Hasegawa T, Chiba K, Shiraishi Y, Du J, Miura F, Morita M, Toh Y, Hirakawa M, Shioyama Y, Ito T, Akimoto T, Miyano S, Shibata T, Mori M, Suzuki Y, Ogawa S,Ishigami K, Mimori K * . The Evolving Genomic Landscape of Esophageal Squamous Cell Carcinoma Under Chemoradiotherapy. Cancer Res. 2021,81(19):4926-4938. doi:10.1158/0008-5472.CAN-21-0653.
9. Hu Q, Masuda T, Koike K, Sato K, Tobo T, Kuramitsu S, Kitagawa A, Fujii A,Noda M, Tsuruda Y, Otsu H, Kuroda Y, Ito S, Oki E, Mimori K*. Oxysterol binding protein-like 3 (OSBPL3) is a novel driver gene that promotes tumor growth in part through R-Ras/Akt signaling in gastric cancer. Sci Rep. 2021, 11(1):19178. doi: 10.1038/s41598-021-98485-9.
10. Ono H, Arai Y, Furukawa E, Narushima D, Matsuura T, Nakamura H, Shiokawa D, Nagai M, Imai T, Mimori K, Okamoto K, Hippo Y, Shibata T, Kato M*. Single-cell DNA and RNA sequencing reveals the dynamics of intratumor heterogeneity in a colorectal cancer model. BMC Biol. 2021, 19(1):207. doi:10.1186/s12915-021-01147-5.